RxSight, Inc. (RXST) stock

RXSTNasdaqOphthalmic GoodsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/3074% below fair value

$5.38+0.10 (+1.89%)

Close on Nov 12, 2026Market cap $223.77MP/E –Yield –

RxSight EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

RxSight's EPS for the twelve months ending Jun 30, 2026 was -$1.13. For fiscal 2025 it was -$0.95. The highest annual figure on record is $0.15 in fiscal 2020.

Annual eps

Period	Period end	Value	Change
FY2025	Dec 31, 2025	-$0.95	–
FY2024	Dec 31, 2024	-$0.71	–
FY2023	Dec 31, 2023	-$1.41	–
FY2022	Dec 31, 2022	-$2.41	–
FY2021	Dec 31, 2021	-$3.57	-2480.0%
FY2020	Dec 31, 2020	$0.15	–

Quarterly eps

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q2 FY2026	Jun 30, 2026	-$0.29	–
Q1 FY2026	Mar 31, 2026	-$0.38	–
Q4 FY2025	Dec 31, 2025	-$0.22	–
Q3 FY2025	Sep 30, 2025	-$0.24	–
Q2 FY2025	Jun 30, 2025	-$0.29	–
Q1 FY2025	Mar 31, 2025	-$0.20	–
Q4 FY2024	Dec 31, 2024	-$0.15	–
Q3 FY2024	Sep 30, 2024	-$0.16	–
Q2 FY2024	Jun 30, 2024	-$0.16	–
Q1 FY2024	Mar 31, 2024	-$0.25	–
Q4 FY2023	Dec 31, 2023	-$0.26	–
Q3 FY2023	Sep 30, 2023	-$0.35	–
Q2 FY2023	Jun 30, 2023	-$0.40	–
Q1 FY2023	Mar 31, 2023	-$0.42	–
Q4 FY2022	Dec 31, 2022	-$0.56	–
Q3 FY2022	Sep 30, 2022	-$0.61	–
Q2 FY2022	Jun 30, 2022	-$0.61	–
Q1 FY2022	Mar 31, 2022	-$0.64	–
Q3 FY2021	Sep 30, 2021	-$0.68	–
Q2 FY2021	Jun 30, 2021	-$3.53	–
Q1 FY2021	Mar 31, 2021	-$1.70	–
Q3 FY2020	Sep 30, 2020	$0.00	–
Q2 FY2020	Jun 30, 2020	$0.00	–